Lawrence N. Marinucci

Statistics

Publications

Citations

1.5K

H-Index

Active since

1993

Affiliations

Acorda Therapeutics (United States)(Current)

Evergreen Health Medical Center

Cleveland Clinic

University of Rochester

University of Rochester Medical Center

Lawrence N. Marinucci is an author at Acorda Therapeutics (United States) specializing in pharmacotherapy, multiple sclerosis therapy, and multiple sclerosis.

Publications per year

1993–2015

Publications

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Andrew Goodman, Theodore R. Brown, Lauren Krupp et al. · The Lancet · 2009 · 549 citations

Pharmacy, Neurology, Pharmacotherapy +8

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Andrew Goodman, Theodore R. Brown, Keith R. Edwards et al. · Annals of Neurology · 2010 · 373 citations

Medicine, Pharmacology, Pharmacotherapy +12

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Andrew Goodman, Ted R. Brown, J. A. Cohen et al. · Neurology · 2008 · 178 citations

Education, Pharmacotherapy, Clinical Pharmacology +16

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study

Andrew Goodman, Jeffrey A. Cohen, Anne H. Cross et al. · Multiple Sclerosis Journal · 2007 · 151 citations

Medicine, Pharmacology, Pharmacotherapy +14

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis

Craig I Coleman, Diana M Sobieraj, Lawrence N. Marinucci · Current Medical Research and Opinion · 2011 · 104 citations

Health Professions, Neurology, Pharmacotherapy +13

1–5 of 8